Research reports by Haitong Securities: China Pacific Insurance has a relatively low valuation, rated as "outperform" in the market.
China Taibao (601601): Changhang's transformation and further promotion of business performance continues to be outstanding
Jefferies Financial: Q2 profits from mainland insurance companies pave the way for recovery in the second half of the year, raising target prices for China Life Insurance, China Pacific Insurance, and other companies.
Research reports from Zhongjin: Medium-term new business value continues to increase in life insurance stocks, and Taibao is the first in the industry to promote it.
Major bank rating | UBS Group: Ping An Insurance's issuance of convertible bonds should not completely surprise the market. Its target price is HKD56.
Credit rating of major banks|DBS: Raised target price for most life insurance companies and revised industry outlook to attractive.
Nomura Adjusts China Pacific Insurance (Group)'s Price Target to HK$29.04 From HK$26.14, Keeps at Buy
China Taibao (601601): Premium income changed year-on-year, and the transformation of Changhang progressed in depth
Bank Ratings | J.P. Morgan Chase: Domestic Insurance Stocks Prefer China Ping An Upgrades China Taibao and Xinhua Insurance
China Taibao (601601) 2023 Annual Report Review: NBV maintains relatively rapid growth and leads the way in industrial insurance premium growth
China Taibao (601601) 2024 Quarterly Report Review: NBV High Production Insurance Cost Rate Improvement
Bank Rating | CMB International: Lowering China's Taibao Target Price to HK$24.8 to Maintain “Buy” Rating
CPIC(2601.HK):VNB GROWTH ACCELERATED; NP TURNED POSITIVE YOY
China Taibao (601601): New business value has achieved relatively rapid growth, profit performance is steady, and the asset side is expected to pick up
Big Bank Ratings|Damo: Maintaining Taibao's “Accumulation” Rating Outperforms Expectations in the First Quarter
Bank Rating | Goldman Sachs: Giving China Taibao “Neutral” Rating Upgraded Earnings Per Share for 2024-26
Nomura Adjusts China Pacific's Price Target to HK$26.14 From HK$25.12, Keeps at Buy
China Taibao (601601): NBV led the industry by +30.7% YoY, COR bucked the trend and improved
China Taibao (601601): NBV is leading the industry, and the transformation results of NBV are becoming more and more prominent
China Taibao (2601.HK): Excellent performance on both sides of assets and liabilities
No Data